ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RNVA Rennova Health Inc (PK)

0.0001
0.0001 (9,900.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Rennova Health Inc (PK) USOTC:RNVA OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.000099 9,900.00% 0.0001 0.000001 0.0001 0.0001 0.000001 0.00005 6,311,517 19:01:19

Statement of Changes in Beneficial Ownership (4)

30/09/2021 9:16pm

Edgar (US Regulatory)


FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Diamantis Christopher Eric
2. Issuer Name and Ticker or Trading Symbol

Rennova Health, Inc. [ RNVA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
_____ Officer (give title below)    __X__ Other (specify below)
Former 10% Owner
(Last)          (First)          (Middle)

1143 GLENDALE LANE
3. Date of Earliest Transaction (MM/DD/YYYY)

9/17/2021
(Street)

NASHVILLE, TN 37204
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock (1)        95450000 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants to Purchase Common Stock $0.007           8/27/2021 (2)8/27/2024 Common Stock 47500000  47500000 D  
Series M Convertible Redeemable Preferred Stock  (3)           (2) (2)Common Stock  (3) 20180 D  

Explanation of Responses:
(1) This Form 4 is being filed to reflect the fact that, as of September 17, 2021, Mr. Diamantis beneficially owned less than 10% of the Common Stock of the Issuer. Mr. Diamantis has not effected any transactions in the securities of the Issuer since the August 27, 2021 Exchange Agreement reported on his prior Form 4. Due to conversions of the Issuer's preferred stock by parties other than Mr. Diamantis, the Issuer's outstanding Common Stock has increased dramatically. As of September 17, 2021, there were 1,057,349,999 shares of Common Stock issued and outstanding and, as a result, Mr. Diamantis' beneficial ownership has decreased to below 10%.
(2) The exercise of the Warrants and the conversion of the Series M Convertible Redeemable Preferred Stock (the "Series M Preferred Stock") are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of September 17, 2021. The Series M Preferred Stock has no stated maturity date.
(3) The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Diamantis Christopher Eric
1143 GLENDALE LANE
NASHVILLE, TN 37204



Former 10% Owner

Signatures
/s/ Christopher E. Diamantis9/30/2021
**Signature of Reporting PersonDate

1 Year Rennova Health (PK) Chart

1 Year Rennova Health (PK) Chart

1 Month Rennova Health (PK) Chart

1 Month Rennova Health (PK) Chart

Your Recent History

Delayed Upgrade Clock